| Literature DB >> 25976680 |
Pengli Zheng1, Qiao Wang1, Junlin Teng1, Jianguo Chen2.
Abstract
Tumor metastasis is a key cause of cancer mortality, and inhibiting migration of cancer cells is one of the major directions of anti-metastatic drug development. Calumenin and fibulin-1 are two extracellular proteins that synergistically inhibit cell migration and tumor metastasis, and could potentially be served as targets for pharmacological research of anti-metastatic drugs. This review briefly introduces the multi-function of these two proteins, and discusses the mechanism of how they regulate cell migration and tumor metastasis.Entities:
Keywords: Anti-metastasis; Calumenin; Cell migration; Fibulin-1
Mesh:
Substances:
Year: 2015 PMID: 25976680 DOI: 10.1016/j.phrs.2015.05.001
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658